In an interview conducted at the Association for Research in Vision and Ophthalmology Annual Meeting, May 5-9, 2023, Jordana Fein, MD, MS, Retina Group of Washington Fairfax, Virginia,…
Lung cancer comes in two main types: non-small cell and small cell. Each has different patterns, growth rates, and treatment needs. Smoking is the top risk factor, but…
Making use of the many readily accessible resources and services available to both physicians and patients can help alleviate awkwardness that may arise when discussing the subject of…
Many important properties and potential health benefits of nicotinamide riboside have been identified since discovery of its role in the human NAD metabolic cycle over a decade ago.
Robotic-arm assisted surgery using the Stryker Mako System may yield better functional results for total hip, as well as for partial or total knee replacement patients due to…
A recent study published in Lancet Neurology reveals important associations between MSH3 gene mutations and Huntington’s disease progression and disease burden.
Current therapeutic options for non-small cell lung cancer (NSCLC) are ever-evolving with the possibility of solely immunotherapy-based treatment regimens on the near horizon for certain patients.
Nicotinamide riboside appears to be the best precursor supplement available to help maintain or increase NAD+ levels. All cells and tissues can use it, and at high doses…
